Abstract

Purposes

To generate a nomogram to predict parotid gland (PG) overdose and to quantify the dosimetric benefit of weekly replanning based on its findings, in the context of intensity-modulated radiotherapy (IMRT) for locally-advanced head and neck carcinoma (LAHNC).

Material and methods

Twenty LAHNC patients treated with radical IMRT underwent weekly computed tomography (CT) scans during IMRT. The cumulated PG dose was estimated by elastic registration. Early predictors of PG overdose (cumulated minus planned doses) were identified, enabling a nomogram to be generated from a linear regression model. Its performance was evaluated using a leave-one-out method. The benefit of weekly replanning was then estimated for the nomogram-identified PG overdose patients.

Results

Clinical target volume 70 (CTV70) and the mean PG dose calculated from the planning and first weekly CTs were early predictors of PG overdose, enabling a nomogram to be generated. A mean PG overdose of 2.5Gy was calculated for 16 patients, 14 identified by the nomogram. All patients with PG overdoses >1.5Gy were identified. Compared to the cumulated delivered dose, weekly replanning of these 14 targeted patients enabled a 3.3Gy decrease in the mean PG dose.

Conclusion

Based on the planning and first week CTs, our nomogram allowed the identification of all patients with PG overdoses >2.5Gy to be identified, who then benefitted from a final 4Gy decrease in mean PG overdose by means of weekly replanning.

Details

Title
A Nomogram to predict parotid gland overdose in head and neck IMRT
Author
Castelli, J; Simon, A; Rigaud, B; Lafond, C; Chajon, E; Ospina, J D; Haigron, P; Laguerre, B; A Ruffier Loubiere; Benezery, K; de Crevoisier, R
Publication year
2016
Publication date
2016
Publisher
BioMed Central
e-ISSN
1748-717X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1800868772
Copyright
Copyright BioMed Central 2016